FDA Clears iOS App to Simplify Diabetes Management

August 3, 2021

The U.S. Food and Drug Administration this week cleared Abbott’s FreeStyle® Libre 2 iOS application for use with compatible iPhones, to pair with its FreeStyle Libre 2 integrated continuous glucose monitoring (iCGM) system. Approved for adults and children (4 and older) with diabetes, the new app enables users to get glucose readings directly on their […]

To view the full Member Resource, please Log in

TOPICS IN THIS ARTICLE:

←Devil in the Details: The Impact of the First Interchangeable Biosimilar Insulin

Endocrine Society Priorities Included in Appropriations Legislation Advancing in House→

View Archives

Join the Global Movement Advancing Endocrine Science and Medicine

Become a part of a community of 18,000-plus endocrine investigators and clinicians who conduct research and provide quality patient care in more than 100 countries. Advance your career and the field of endocrinology through our many educational, leadership and advocacy opportunities.

Join Today